Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when UFPT files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: UFPT UFP TECHNOLOGIES INC 8-K

UFP Technologies reports record Q2 2026: sales $174.0M (+15.1% YoY), net income $20.9M (+21.4%)

Filed August 3, 2026 · Period ending August 3, 2026 · ~1 min read

5 key changes 1 high relevance 2 sections

Key Changes

  • high

    Net sales reached $174.0M in Q2 2026, up 15.1% from $151.2M in Q2 2025, with net income of $20.9M (up 21.4% from $17.2M). GAAP diluted EPS was $2.68 versus $2.21 prior year; adjusted EPS was $2.92 versus $2.50.

    Exhibit 99.1 view on EDGAR →
  • medium

    Gross margin expanded 50 basis points to 29.3% from 28.8% year-over-year, despite near-term mix and margin pressure in U.S. operations from ongoing Dominican Republic capacity investments.

    Exhibit 99.1 view on EDGAR →
  • medium

    Top five customers grew 14.7% in Q2, while the remainder of MedTech business grew 19.7%; non-medical business was flat, indicating broad-based MedTech growth beyond largest accounts.

    Exhibit 99.1 view on EDGAR →
  • medium

    SG&A expenses rose 21.8% to $22.8M (13.1% of sales versus 12.4% prior year), driven by leadership team investments in business development, operations, and legal to support platform growth.

    Exhibit 99.1 view on EDGAR →
  • medium

    Dominican Republic investments are generating early operational benefits but taking longer than anticipated to fully realize, creating near-term U.S. margin pressure with expected long-term structural improvements.

    Exhibit 99.1 view on EDGAR →

Summary

UFP Technologies delivered strong Q2 2026 results with double-digit revenue and earnings growth. Net sales of $174.0 million rose 15.1% year-over-year, while net income of $20.9 million increased 21.4%. The company achieved gross margin expansion of 50 basis points to 29.3% despite near-term headwinds from its Dominican Republic capacity investments, which are taking longer than expected to fully realize benefits but are generating early operational improvements.

Growth was broad-based across the MedTech customer base, with the top five customers up 14.7% and the remainder of MedTech up 19.7%, while non-medical business remained flat. The company is investing in its leadership team to support platform growth, reflected in SG&A rising to 13.1% of sales from 12.4%. For retail holders, the results demonstrate solid execution and market share gains in MedTech, though the Dominican Republic transition and elevated SG&A warrant monitoring as the company scales its operations and cost structure.

Section-by-Section Diff

Event · Item 2.02 — Results of Operations and Financial Condition

~200 words

UFP Technologies disclosed Q2 2026 financial results via press release.

1 Added
Added Q2 2026 earnings announcement high

Added in current filing · verify on EDGAR →

On August 3, 2026, UFP Technologies, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2026.

The company announced its second quarter 2026 financial results through a press release. The 8-K body itself does not contain specific financial figures; those would be in the attached Exhibit 99.1 press release, which was not provided in the input text.

Event · Exhibit 99.1

1 Added
Added SG&A increase medium

Added in current filing · view on EDGAR → · paraphrased

SG&A increased 21.8% to $22.8 million for the second quarter of 2026 compared to $18.7 million in the same quarter of 2025. As a percentage of sales, SG&A increased to 13.1% in the second quarter of 2026, from 12.4% in the same period of 2025. ... As a percentage of sales, adjusted SG&A increased to 11.7% ... for the three- ... months ended June 30, 2026 ... from 10.8% ... respectively in the same periods of 2025.

SG&A expenses rose 21.8% to $22.8 million in Q2 2026 from $18.7 million in Q2 2025, increasing as a percentage of sales to 13.1% from 12.4%. Adjusted SG&A as a percentage of sales increased to 11.7% from 10.8%. Management attributes the increase to strengthening the leadership team with experienced executives in business development, operations, and legal to support platform growth.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 4, 2026 · How we verify